Status: Recruiting
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Performance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human Immunodeficiency Virus (HIV), Hepatitis B and C and Syphilis) from serum, plasma samples collected prospectively or retrospectively in Ivory Coast and Kenya.
Participants needed: 2,950
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: MagIA DiagnosticsUpdated: Feb 2, 2026Locations: 2
Eligibility criteria
Provide informed consent for participation in this study. [+14]
Samples from patients below 18 years of age